Search
Add filters:
Use filters to refine the search results.
Results 1-4 of 4 (Search time: 0.007 seconds).
- previous
- 1
- next
Item hits:
Issue Date | Title | Author(s) |
---|---|---|
7-Apr-2022 | MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment | Alcón, Clara; Martín, Fernando; Prada, Estela; Mora, Jaume; Soriano, Aroa; Guillén, Gabriela; Gallego, Soledad; Roma, Josep; Samitier i Martí, Josep; Villanueva, Alberto; Montero, Joan |
9-Sep-2021 | MCL-1 Inhibition Overcomes Anti-apoptotic Adaptation to Targeted Therapies in B-Cell Precursor Acute Lymphoblastic Leukemia | Manzano Muñoz, Albert; Alcón, Clara; Menéndez, Pablo; Ramírez, Manuel; Seyfried, Felix; Debatin, Klaus-Michael; Meyer, Lüder H.; Samitier i Martí, Josep; Montero, Joan |
15-Aug-2020 | Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance | Alcón, Clara; Manzano Muñoz, Albert; Prada, Estela; Mora Salvador, Jaume; Soriano, Aroa; Guillén, Gabriela; Gallego, Soledad; Roma, Josep; Samitier i Martí, Josep; Villanueva Garatachea, Alberto; Montero, Joan |
2-Jul-2021 | ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins | Alcón, Clara; Gómez Tejeda Zañudo, Jorge; Albert, Reka; Wagle, Nikhil; Scaltriti, Maurizio; Anthony, Letai; Samitier i Martí, Josep; Montero, Joan |
Discover
Subject